Tools for Practice Outils pour la pratique


#127 What can’t they do: Steroids for my sore throat?


CLINICAL QUESTION
QUESTION CLINIQUE
Do corticosteroids reduce pain in patients with acute pharyngitis?


BOTTOM LINE
RÉSULTAT FINAL
Corticosteroids (when added to antibiotics) reduce pain in patients with sore throats. For every four patients treated, one additional patient will be pain free at 24 hoursespecially in adults with documented streptococcus pharyngitis and more severe symptoms 



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
Highest quality systematic review (published twice).1,2 
  • Eight randomized placebo-controlled trials (RCTs) of single-dose oral or intramuscular steroids (commonly dexamethasone) in 743 children or adults with sore throats 
    • Patients given steroids were more likely pain free at 
      • 24 hours [39% vs. placebo 12%, number needed to treat (NNT)=4].  
      • 48 hours [76% vs. 47%, NNT=4].  
    • Pain relief onset ~6 hours faster.  
  • Adults, patients with group A streptococcus (GAS), and those with more severe symptoms seem to benefit more  
  • Limitations:   
    • Potential confounders (e.g. analgesic use) not always reported.3,4,5 
    • Treatment differed from normal clinical practice 
      • All patients in adult studies were given antibiotics, often without throat swabs.1  
  • Other reviews found similar results.6,7 
Highest quality/most relevant RCTs (similar baseline characteristics, more complete reporting, and used oral dexamethasone): 
  • Pediatrics: 184 children in Canadian emergency department with <48 hours of moderate sore throat found dexamethasone (0.6mg/kg, max 10mg):8 
    • Decreased time to pain relief by 5.5 hours in GAS positive patients, but increased time to pain relief by four hours (not statistically significant) in GAS negative patients. 
  • Adults: 120 patients in American emergency department with moderate-severe sore throat (all given antibiotics, ~33-43% GAS positive)9 found that patients given 10mg dexamethasone were: 
    • More likely pain free at 24 hours (29.3% vs. 11.1%, NNT=6). 
Context:  
  • Most sore throats resolve in 2-5 days.10 
  • Steroid adverse events: No differences reported1,2 but concerns about using in patients who actually have leukemia or lymphoma.11 
  • Current guidelines do not recommend steroids for pharyngitis.12 
 


Latest Tools for Practice
Derniers outils pour la pratique

#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?

What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
Read Lire 0.25 credits available Crédits disponibles

#377 How to slow the flow IV: Combined oral contraceptives

In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
Read Lire 0.25 credits available Crédits disponibles

#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)

What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • Kevin Haley MD CCFP
  • Michael Kolber BSc MD CCFP MSc

1. Hayward G, Thompson M, Heneghan C, et al. BMJ. 2009; 339:b2976.

2. Hayward G, Thompson MJ, Perera R, et al. Cochrane Database Syst Rev. 2012; (10):CD008268.

3. Niland ML, Bonsu BK, Nuss KE, et al. Pediatr Infect Dis J. 2006; 25(6):477-81.

4. Kiderman A, Yaphe J, Bregman J, et al. Br J Gen Prac. 2005; 55(512):218-21.

5. Marvez-Valls EG, Ernst AA, Gray J, et al. Acad Emerg Med. 1998; 5(6):567-72.

6. Wing A, Villa-Roel C, Yeh, et al. Acad Emerg Med. 2010; 17:476-83.

7. Korb K, Scherer M, Chenot JF. Ann Fam Med. 2010; 8:58-63.

8. Bulloch B, Kabani A, Tenenbein M. Ann Emerg Med. 2003; 41(5):601-8.

9. Wei JL, Kasperbauer JL, Weaver AL, et al. Laryngoscope 2002; 112(1):87-93.

10. Thompson M, Cohen HD, Vodicka TA, et al. BMJ. 2013; 347:f7027.

11. Sadowitz PD, Page NE, Crowley K. Pediatr Emer Care. 2012; 28:807-9.

12. Shulman ST, Bisno AL, Clegg HW, et al. Clin Infect Dis. 2012; 55(10):e86-102.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.